CÁNCER GÁSTRICO - inmunoterapia
Update: 2025-05-14
Description
no te pierdas los últimos avances
HER-2, PD-L1, MSI-H/dMMR
Trastuzumab, Nivolumab, Pembrolizumab
Síguenos en:
Instagram: @cirugiadocente
Podcast: "Entre Cirugías" y "Pioneros"
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
